Medical equipments, pharmaceuticals and personal care products

Tender description

NHS Blood and Transplant (NHSBT) intends to undertake an OJEU tender exercise for the supply of HLA typing systems by next generation sequencing technologies. Prior to commencing the formal procurement process, NHSBT would like to consult the market to improve our knowledge of all current and future systems available over the next 5 years to assess their potential application into clinical practice. This will aid identification of opportunities and gauge market interest in this field. It is NHSBT's intention to hold a supplier engagement day in May 2017. To enable NHSBT to finalise arrangements, interested organisations are to send an expression of interest via email to james.davenport@nhsbt.nhs.uk by no later than 17:00 (GMT) on 21.4.2017. This should include a list of your potential attendees and a brief overview (or a website link) of the Goods / Services which might be offered. Please include options, if available, to offer a managed service contract. Histocompatibility and Immunogenetics (H&I) is a strategic business function of NHSBT, providing testing and support in transplantation, specialised transfusion including the supply of selected blood products, immunogenetics, platelet and granulocyte immunology. These services are supplied through a national network of 6 laboratories located at NHSBT Birmingham, Filton (Bristol), Colindale, Newcastle, Sheffield, and Tooting. These services support the diagnosis and/or treatment of a variety of medical conditions and are relevant in the following clinical areas; Solid organ transplantation and clinical advice for donor selection, Haematopoietic stem cell transplantation and clinical advice for donor selection, Blood transfusion and transfusion reactions (SHOT), Platelet refractoriness and provision of HLA/HPA selected components, Platelet and Granulocyte immunology, Immunogenetics including diagnostic testing and pharmacogenetics and Haematopoietic stem cell donor registry typing.